PORTFOLIO NEWS Incyte Completes Acquisition of Escient Pharmaceuticals May 30, 2024 Read More » A2 Bio Highlights Progress of CAR T-Cell Clinical Programs in Three Poster Presentations during the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting May 29, 2024 Read More » Nurix Therapeutics Appoints Paula G. O’Connor, M.D., as Chief Medical Officer and Pasit Phiasivongsa, Ph.D., as Chief Technical Officer May 28, 2024 Read More » A2 Bio Announces First Patient Dosed in EVEREST-2 Phase 1 Clinical Trial of Novel Mesothelin Logic-Gated CAR T May 16, 2024 Read More » (Carmot) Roche Reports Positive Phase Ib Results For Its Dual GLP-1/GIP Receptor Agonist CT-388 in People with Obesity May 16, 2024 Read More » Tenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update May 14, 2024 Read More » RAPT Therapeutics Reports First Quarter 2024 Financial Results May 9, 2024 Read More » ORIC Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Updates May 6, 2024 Read More » Remix Therapeutics™ Announces First Patients Dosed in Two Phase 1 Clinical Trials Investigating REM-422 for Treatment of Adenoid Cystic Carcinoma (ACC) and Acute Myeloid Leukemia/Myelodysplastic Syndromes (AML/MDS) May 2, 2024 Read More » Cajal Neuroscience and Creyon Bio Announce Partnership to Develop Oligonucleotide-Based Medicines for Neurodegenerative Diseases May 1, 2024 Read More » « Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Page10 Page11 Page12 Page13 Page14 Page15 Page16 Page17 Page18 Page19 Page20 Next »
A2 Bio Highlights Progress of CAR T-Cell Clinical Programs in Three Poster Presentations during the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting May 29, 2024 Read More »
Nurix Therapeutics Appoints Paula G. O’Connor, M.D., as Chief Medical Officer and Pasit Phiasivongsa, Ph.D., as Chief Technical Officer May 28, 2024 Read More »
A2 Bio Announces First Patient Dosed in EVEREST-2 Phase 1 Clinical Trial of Novel Mesothelin Logic-Gated CAR T May 16, 2024 Read More »
(Carmot) Roche Reports Positive Phase Ib Results For Its Dual GLP-1/GIP Receptor Agonist CT-388 in People with Obesity May 16, 2024 Read More »
Tenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update May 14, 2024 Read More »
ORIC Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Updates May 6, 2024 Read More »
Remix Therapeutics™ Announces First Patients Dosed in Two Phase 1 Clinical Trials Investigating REM-422 for Treatment of Adenoid Cystic Carcinoma (ACC) and Acute Myeloid Leukemia/Myelodysplastic Syndromes (AML/MDS) May 2, 2024 Read More »
Cajal Neuroscience and Creyon Bio Announce Partnership to Develop Oligonucleotide-Based Medicines for Neurodegenerative Diseases May 1, 2024 Read More »
